A detailed history of Creative Planning transactions in Evolus, Inc. stock. As of the latest transaction made, Creative Planning holds 12,488 shares of EOLS stock, worth $199,183. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,488
Holding current value
$199,183
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$10.45 - $13.76 $130,499 - $171,834
12,488 New
12,488 $135,000
Q1 2022

May 16, 2022

SELL
$5.22 - $11.78 $52,440 - $118,341
-10,046 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$5.37 - $8.38 $53,947 - $84,185
10,046 New
10,046 $65,000
Q3 2021

Nov 10, 2021

SELL
$7.36 - $13.67 $80,562 - $149,631
-10,946 Closed
0 $0
Q2 2021

Aug 04, 2021

SELL
$8.42 - $13.96 $145,287 - $240,879
-17,255 Reduced 61.19%
10,946 $138,000
Q1 2021

Apr 30, 2021

SELL
$3.2 - $16.51 $4,553 - $23,493
-1,423 Reduced 4.8%
28,201 $366,000
Q4 2020

Jan 29, 2021

BUY
$2.92 - $4.84 $7,726 - $12,806
2,646 Added 9.81%
29,624 $100,000
Q3 2020

Nov 05, 2020

BUY
$3.03 - $5.48 $30 - $54
10 Added 0.04%
26,978 $105,000
Q2 2020

Jul 23, 2020

BUY
$3.53 - $6.17 $7,924 - $13,851
2,245 Added 9.08%
26,968 $143,000
Q1 2020

May 05, 2020

BUY
$3.53 - $12.21 $7,060 - $24,420
2,000 Added 8.8%
24,723 $103,000
Q4 2019

Jan 30, 2020

BUY
$11.58 - $17.37 $11,580 - $17,370
1,000 Added 4.6%
22,723 $277,000
Q3 2019

Nov 01, 2019

SELL
$13.91 - $19.87 $695 - $993
-50 Reduced 0.23%
21,723 $339,000
Q2 2019

Jul 26, 2019

BUY
$13.19 - $28.36 $287,185 - $617,482
21,773 New
21,773 $318,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $895M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.